Mark trusheim biography

  • Mark Trusheim is.
  • I am the Founder and President of Co-Bio Consulting, LLC as well as Strategic Director of NEWDIGS at the MIT Center for Biomedical Innovation.
  • Mark Trusheim is a Visiting Scientist at the MIT Sloan School of Management and Strategic Director, NEWDIGS at the MIT Center for Biomedical Innovation.

    • •

    Mark Trusheim

    Mark Trusheim is Strategic Director, MIT NEWDIGS where he also co-leads the Financing and reimbursement of Cures in the US (FoCUS) Project; and a Visiting Scientist at the MIT Sloan School of Management.  Through okänt he has also served as a Special Government Employee for the FDA’s Office of the Commissioner.  

    Mark’s research focuses on the economics of biomedical innovation, especially precision financing for patient tillgång, precision medicine, adaptive pathways, platform trials, biosimilars, and digital health advances. 

    Mark is also President of Co-Bio Consulting, LLC. Prior to MIT, his career spanned big data at Kenan Systems, marknadsföring at Searle Pharmaceuticals, eHealth as Vice President of Monsanto Health Solutions, genomics as President of Cereon Genomics, and policy as the President of the Massachusetts Biotechnology Council. 

    He holds degrees in Chemistry from Stanford University and Management from MIT.

    Back to Advisory Board

  • mark trusheim biography

    • •

    Associates

    Biohealth Management, LLC is involved in many different types of life sciences projects from business, market and clinical strategy and development to supporting international government agencies in globalization. Dr. Levy has significant expertise and experience in all of the areas (Details listed under web page Services and Sample Engagements). In addition to Dr. Levy, Biohealth Management has a team of senior experts with a broad knowledge and experience base to participate as part of the Biohealth Management team.

    Christa R. Bleyleben – Senior Partner

    Christa Bleyleben is the Founder and Managing Partner of MassGlobal Partners LLC, an international strategy and tactical advisory firm, helping innovative companies to internationalize their businesses. Christa brings more than 25 years of experience in building global relationships – working in executive management roles in both the public as well as private sectors. In her prior career, Christa was Executive

    •

    Nathan Sigworth, PharmaCCX's co-founder and CEO said "I am looking forward to working with Mark on several areas of our business. Mark's insights to how treatments are priced and the evolving financing and reimbursement landscape will help us build a better product to address the needs of both payers and pharma, and consequently have a positive impact on patients."

    Mark's research focuses on the economics of biomedical innovation, especially precision financing for patient access, precision medicine, adaptive pathways, platform trials, biosimilars, and digital health advances.

    "I look forward to working with Nathan and the team at PharmaCCX" said Trusheim. "It is exciting to see areas I've studied for years as part of my research being pushed to new limits using a technology solution"

    Mark is also President of Co-Bio Consulting, LLC. Prior to MIT, his career spanned big data at Kenan Systems, marketing at Searle Pharmaceuti